封面
市场调查报告书
商品编码
1687622

週边干预市场规模、份额及成长分析(按干预类型、设备类型、适应症、技术、最终用户和地区)—2025 年至 2032 年行业预测

Peripheral Interventions Market Size, Share, and Growth Analysis, By Intervention Type (Atherectomy, Stent Implantation), By Device Type (Catheters, Stents), By Indication, By Technology, By End User, By Region - Industry Forecast 2025-2032

出版日期: | 出版商: SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2023 年外周干预市场规模价值 102 亿美元,预计将从 2024 年的 111.3 亿美元增长到 2032 年的 223.4 亿美元,预测期内(2025-2032 年)的复合年增长率为 9.1%。

高血压、糖尿病、肥胖、吸烟和高碳水化合物饮食等因素导致心血管疾病(CVD)的流行,这是周边干预需求的主要驱动因素。为了应对这项健康挑战,世界各地,尤其是新兴市场的导管实验室数量显着增加,专门从事该领域的医疗保健专业人员的数量也相应增加。导管室在心血管疾病的诊断和治疗中变得越来越重要,其存在正在扩大,特别是在开发中国家。支持介入心臟病学以外多种程序的混合实验室的出现凸显了该行业的技术创新。例如,印度的心导管实验室数量最近增加了一倍多,同时血管成形术的数量也激增,预计这将推动全球医疗保健支出和周边介入服务的进一步成长。

目录

介绍

  • 调查目的
  • 研究范围
  • 定义

调查方法

  • 资讯采购
  • 二次资料和一次资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分机会分析

市场动态与展望

  • 市场概览
  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特的分析

关键市场考察

  • 关键成功因素
  • 竞争程度
  • 主要投资机会
  • 市场生态系统
  • 市场吸引力指数(2024年)
  • PESTEL分析
  • 总体经济指标
  • 价值链分析
  • 定价分析

外周干预市场规模(按干预类型和复合年增长率) (2025-2032)

  • 市场概览
  • 切除术
  • 支架置入术
  • 血管成形术
  • 血栓切除术
  • 栓塞治疗

外周介入市场规模(按设备类型和复合年增长率)(2025-2032)

  • 市场概览
  • 导管
  • 支架
  • 导管导引线
  • 气球
  • 栓塞线圈

週边介入市场规模(按适应症和复合年增长率) (2025-2032)

  • 市场概览
  • 冠状动脉疾病
  • 中风
  • 周边动脉疾病
  • 肾动脉狭窄
  • 颈动脉狭窄

週边干预市场规模(依技术及复合年增长率) (2025-2032)

  • 市场概览
  • 药物释放型支架
  • 球囊扩张型支架
  • 自动扩张型支架
  • 旋动脉粥状硬化斑块切除术
  • 定向动脉粥状硬化斑块切除术

外周干预市场规模(按最终用户和复合年增长率) (2025-2032)

  • 市场概览
  • 医院
  • 门诊手术中心
  • 诊所
  • 研究组织

週边干预市场规模(按地区)及复合年增长率(2025-2032)

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业市场定位(2024年)
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市场占有率分析(2024年)
  • 主要企业简介
    • 公司详情
    • 产品系列分析
    • 公司分部份额分析
    • 收益与前一年同期比较对比(2022-2024 年)

主要企业简介

  • Medtronic plc(Ireland)
  • Abbott Laboratories(USA)
  • Boston Scientific Corporation(USA)
  • Becton, Dickinson and Company(BD)(USA)
  • Philips(Netherlands)
  • Terumo Corporation(Japan)
  • Cook Medical(USA)
  • Cardinal Health, Inc.(USA)
  • B. Braun Melsungen AG(Germany)
  • Getinge AB(Sweden)
  • Merit Medical Systems, Inc.(USA)
  • BIOTRONIK SE & Co. KG(Germany)
  • Endologix, Inc.(USA)
  • ArtVentive Medical Group, Inc.(USA)
  • Inari Medical, Inc.(USA)
  • Bentley InnoMed GmbH(Germany)
  • Gore Medical(USA)
  • MicroPort Scientific Corporation(China)

结论和建议

简介目录
Product Code: SQMIG35D2214

Peripheral Interventions Market size was valued at USD 10.2 billion in 2023 and is poised to grow from USD 11.13 billion in 2024 to USD 22.34 billion by 2032, growing at a CAGR of 9.1% during the forecast period (2025-2032).

The rising incidence of cardiovascular disorders (CVD) is significantly driving demand for peripheral interventions, fueled by factors like hypertension, diabetes, obesity, smoking, and high-carb diets. To address this health issue, there is a notable increase in catheterization laboratories (cath labs) globally, particularly in emerging markets, accompanied by a growing number of healthcare professionals specializing in this field. Cath labs are becoming essential for diagnosing and treating CVD, and their presence is expanding, especially in developing nations. The advent of hybrid labs, which support various procedures beyond cardiovascular interventions, highlights industry innovation. For instance, India's cath labs have more than doubled recently, coinciding with a surge in angioplasties, thereby boosting global healthcare spending and anticipating further growth in peripheral intervention services.

Top-down and bottom-up approaches were used to estimate and validate the size of the Peripheral Interventions market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Peripheral Interventions Market Segments Analysis

Global Peripheral Interventions Market is segmented by Intervention Type, Device Type, Indication, Technology, End User and region. Based on Intervention Type, the market is segmented into Atherectomy, Stent Implantation, Angioplasty, Thrombectomy and Embolization. Based on Device Type, the market is segmented into Catheters, Stents, Guide Wires, Balloons and Embolic Coils. Based on Indication, the market is segmented into Coronary Artery Disease, Stroke, Peripheral Arterial Disease, Renal Artery Stenosis and Carotid Artery Stenosis. Based on Technology, the market is segmented into Drug-Eluting Stents, Balloon-Expandable Stents, Self-Expanding Stents, Rotational Atherectomy and Directional Atherectomy. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers, Clinics and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Peripheral Interventions Market

The increasing prevalence of cardiovascular diseases, particularly peripheral artery disease (PAD), is a significant factor fueling the demand for peripheral intervention solutions. This surge in cases of cardiovascular conditions can largely be linked to risk factors such as hypertension, diabetes, obesity, and a lack of physical activity. As more individuals face these health challenges, there is an urgent need for effective peripheral therapies that address these issues. Consequently, healthcare providers and manufacturers are responding to this growing demand by developing and offering innovative treatment options tailored to manage and mitigate the effects of these cardiovascular disorders.

Restraints in the Peripheral Interventions Market

The Peripheral Interventions market faces significant limitations due to the high costs associated with these treatments, which can be a barrier for many individuals seeking care. In particular, those living in developed regions may find that expensive healthcare options hinder their access to necessary procedures. The financial strain imposed by these interventions can deter patients from pursuing them, ultimately affecting the overall growth and accessibility of the market. Consequently, the high cost of peripheral interventions remains a critical restraint that impacts patient choices and the market's expansion potential in various geographic areas.

Market Trends of the Peripheral Interventions Market

The Peripheral Interventions market is experiencing a significant trend towards the establishment of heterogeneous catheterization labs that integrate various invasive interventional treatments, including cardiac, vascular, neurological, and electrophysiological procedures. These hybrid facilities are gaining traction due to their flexibility, which allows healthcare providers to streamline operations and enhance patient outcomes by combining different specialties under one roof. This trend is driven by the demand for minimally invasive treatment options and the need for efficient patient management, propelling market growth. As technology advances and the focus shifts to personalized care, the hybridization of catheterization labs is set to revolutionize the landscape of peripheral interventions.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Peripheral Interventions Market Size by Intervention Type & CAGR (2025-2032)

  • Market Overview
  • Atherectomy
  • Stent Implantation
  • Angioplasty
  • Thrombectomy
  • Embolization

Global Peripheral Interventions Market Size by Device Type & CAGR (2025-2032)

  • Market Overview
  • Catheters
  • Stents
  • Guide Wires
  • Balloons
  • Embolic Coils

Global Peripheral Interventions Market Size by Indication & CAGR (2025-2032)

  • Market Overview
  • Coronary Artery Disease
  • Stroke
  • Peripheral Arterial Disease
  • Renal Artery Stenosis
  • Carotid Artery Stenosis

Global Peripheral Interventions Market Size by Technology & CAGR (2025-2032)

  • Market Overview
  • Drug-Eluting Stents
  • Balloon-Expandable Stents
  • Self-Expanding Stents
  • Rotational Atherectomy
  • Directional Atherectomy

Global Peripheral Interventions Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Research Institutes

Global Peripheral Interventions Market Size & CAGR (2025-2032)

  • North America (Intervention Type, Device Type, Indication, Technology, End User)
    • US
    • Canada
  • Europe (Intervention Type, Device Type, Indication, Technology, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Intervention Type, Device Type, Indication, Technology, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Intervention Type, Device Type, Indication, Technology, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Intervention Type, Device Type, Indication, Technology, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (BD) (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Philips (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cook Medical (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardinal Health, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Getinge AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merit Medical Systems, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BIOTRONIK SE & Co. KG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Endologix, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ArtVentive Medical Group, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Inari Medical, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bentley InnoMed GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Gore Medical (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MicroPort Scientific Corporation (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations